Australia markets open in 6 hours 15 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
74.86+0.73 (+0.98%)
As of 01:45PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close74.13
Open73.91
Bid74.83 x 900
Ask74.84 x 800
Day's range73.82 - 74.92
52-week range53.22 - 80.59
Volume2,784,349
Avg. volume11,505,719
Market cap159.846B
Beta (5Y monthly)0.39
PE ratio (TTM)24.87
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.16 (2.91%)
Ex-dividend date30 June 2022
1y target estN/A
  • Motley Fool

    2 No-Brainer Bio-Tech Stocks to Buy Right Now

    It can be scary to put your hard-earned money into a bear market. Interestingly, there are some stocks, such as biotech companies Exelixis (NASDAQ: EXEL) and Bristol-Myers Squibb (NYSE: BMY), that are in the limelight by defying the bear market. While the S&P 500 has plunged 13% so far this year, the shares of Exelixis and Bristol-Myers have surged 15% and 23%, respectively.

  • Zacks

    Bristol Myers (BMY) Posts Data From Multiple Myeloma Study

    Bristol Myers (BMY) and partner, 2seventy bio, report top-line data from a late-stage study evaluating Abecma for multiple myeloma patients after two or more lines of prior therapy.

  • Zacks

    Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss

    Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts. CLVS faces the risk of a cash crunch.